THURSDAY, Jan. 9, 2025 -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging,...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

Many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously believed, revealed a recent study....

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic...

MONDAY, Dec. 30, 2024 -- Men with negative multiparametric magnetic resonance imaging (mpMRI) results avoiding biopsy do not have an increased risk...

medlinkHeart disease/medlink and medlinkcancer/medlink are the two leading causes of death in the United States. Patients with late-stage or...

NEW YORK--(BUSINESS WIRE)-- January 10, 2025 -- Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial...

NEW YORK--(BUSINESS WIRE)-- January 10, 2025 -- Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research...

FRIDAY, Jan. 3, 2025 -- Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current standard...